Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

GOLPH3

From Wikipedia, the free encyclopedia
GOLPH3
Identifiers
AliasesGOLPH3, GOPP1, GPP34, MIDAS, Vps74, golgi phosphoprotein 3
External IDsOMIM: 612207; MGI: 1913879; HomoloGene: 56942; GeneCards: GOLPH3; OMA:GOLPH3 - orthologs
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_022130

NM_025673

RefSeq (protein)

NP_071413

NP_079949

Location (UCSC)Chr 5: 32.12 – 32.17 MbChr 15: 12.32 – 12.35 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Golgi phosphoprotein 3 (GOLPH3) is a human protein encoded by GOLPH3 gene. It is a peripheral membrane protein of the Golgi that probably has a regulatory role in Golgi trafficking.[5]

Clinical significance

[edit]

Golph 3 expression is associated with poor prognosis of various cancers of gastrointestinal tract, such as gastric and esophageal squamous cell carcinoma.[6][7] Higher expression of GOLPH3 is reported to be associated with greater sensitivity of colorectal cancer to Fluorouracil therapy.[8]

Notes and references

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000113384 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000022200 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: GOLPH3 golgi phosphoprotein 3".
  6. Wang JH (2013). "High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis". PLOS ONE. 7 (10) e45622. Bibcode:2012PLoSO...745622W. doi:10.1371/journal.pone.0045622. PMC 3462781. PMID 23056210.
  7. Hu BS (Feb 2013). "Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer". Tumour Biol. 34 (1): 515–20. doi:10.1007/s13277-012-0576-z. PMID 23132295. S2CID 6309770.
  8. Wang Z (Jan 2014). "GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy". J. Transl. Med. 12 (1): 15. doi:10.1186/1479-5876-12-15. PMC 4029222. PMID 24444035.